Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study

European Journal of Cancer Part A

Volumn 32, Issue 12, 1996, Pages 2064-2069

  Favaretto, A ^a   Paccagnella, A ^a   Tomio, L ^a   Sartori, F ^b   Cipriani, A ^a   Zuin, R ^a   Reffosco, L ^a   Calabro', F ^b   Rea, F ^b   Ghiotto, C ^a   Chiarion Sileni, V ^a   Oniga, F ^a   Loreggian, L ^a   Fiorentino, M V ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

cisplatin; concurrent chemoradiotherapy; etoposide; hyperfractionated radiotherapy; locally advanced; marginally resectable; NSCLC; pre operative treatment; unresectable

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; ESOPHAGITIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SEPSIS; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0030298249     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00248-1     Document Type: Article

References (17)

1. 1. McCaughan BC, Martini N, Bains MS, McCormack PM. Chest wall invasion in carcinoma of the lung. Therapeutic and prognostic implications. J Thorac Cardiovasc Surg 1985, 89, 836-841.
2. 2. Martini N, Flehinger BJ. The role of surgery in N2 lung cancer. Surg Clin North Am 1987, 67, 1037-1049.
3. 3. Perez CA, Pajak TF, Rubin P, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report of the Radiation Therapy Oncology Group. Cancer 1987, 59, 1874-1881.
4. 4. Warram J. For the Collaborative Investigators. Preoperative irradiation of cancer of the lung: final report of a therapeutic trial, a collaborative study. Cancer 1975, 36, 914-925.
5. 5. Arriagada R, Le Chevalier T, Quoix E, Ruffie P, De Cremoux H, Douillard J-Y. ASTRO Plenary: effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. Int J Rad Oncol Biol Phys 1991, 20, 1183-1190.
6. 6. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med 1990, 323, 940-945.
7. 7. Manual for Staging of Cancer (3rd edn). American Joint Committee on Cancer. Philadelphia, JB Lippincott, 1988.
8. 8. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
9. 9. Prescribing, recording, and reporting photon beam therapy. International Commission on Radiation Unit and Measurements, Washington, District of Columbia, 1993.
10. 10. Ginsberg RJ. Limits and perspectives of surgical resection for non-small cell lung cancer. Lung Cancer 1991, 7, 35-39.
11. 11. Perez CA, Bauer M, Edelstein S, et al. Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Rad Oncol Biol Phys 1986, 12, 539-547.
12. 12. Paccagnella A, Favaretto AG, Brandes A, et al. Cisplatin, etoposide and ifosfamide in non small cell lung carcinoma: a phase II randomized study with cisplatin and etoposide as the control arm. Cancer 1990, 65, 2631-2634.
13. 0 non-small cell lung cancer: long-term follow-up in 41 patients. J Surg Oncol 1989, 40, 266-274.
14. 14. Strauss GM, Herndon JE, Sherman DD, et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10, 1237-1244.
15. 15. Weiden PL, Piantadosi S. For the Lung Cancer Study Group. Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non small cell lung cancer: a phase II study of the Lung Cancer Study Group. J Natl Cancer Inst 1991, 83, 266-272.
16. 16. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/ etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase-II study 8805. J Clin Oncol 1995, 13, 1880-1892.
17. 17. Jacobs RH, Awan A, Bitran JD, et al. Prophylactic cranial irradiation in adenocarcinoma of the lung. A possible role. Cancer 1987, 59, 2016-2019.